OncoTracking™ puts the power of monitoring cancer in the patient's hands. By analyzing a tumor and creating custom assays specific to the uniqueness of the tumor tissue, we can monitor a patient's blood to detect the earlier possible signs that the cancer may have returned. Detecting cancer in its earliest stages can help patients have a better quality of life since the smaller the cancer is, the less treatment may be needed to treat it. This is a proactive way for patients in remission to do everything they can to detect cancer as soon as possible.

That depends on the type of insurance you have and your carrier. Our customer service team at GoPath Laboratories will do everything possible to help determine whether or not OncoTracking™ is covered by submitting the proper codes associated with your treatment to your provider.

All it takes is a phone call to the department of pathology at the facility where your initial surgery was performed. Tumor samples are to be stored for up to 10 years after surgery. You sample belongs to you and should be returned to you, if requested

We always encourage patients to speak with their physicians before any important healthcare decision. However, it is not required that you speak to your doctor before signing up for OncoTracking™. At GoPath Laboratories, we have physicians on staff who can guide you through the testing process and who answer any questions that may arise.

Not yet, though it may be in the future. OncoTracking™ involves recently-developed, cutting-edge technology. Being approved by NCCN Guildelines (the National Comprehensive Cancer Network) takes time, which means that OncoTracking™ has not yet been approved by NCCN. However, we believe this proprietary test process may be extremely valuable for patients in remission, which is why our goal was to make it available for use as soon as it was ready.